![]() | Yahoo! Health - My Alerts - Edit Alert |
Tuesday, Feb 19, 2013 11:11 AM EST | |
NeuroMetrix fourth quarter total revenues decrease to $1.5 million Tue, 19 Feb, 2013 07:35 AM PST NeuroMetrix, Inc., a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today reported business and financial highlights for the quarter and twelve months ended December 31, 2012. Sitting time associated with increased risk of chronic diseases Tue, 19 Feb, 2013 07:21 AM PST ( Kansas State University ) Those who sat for more than four hours per day were significantly more likely to report having a chronic disease such as cancer, diabetes, heart disease and high blood pressure. Health advocates team up for health responsibility Tue, 19 Feb, 2013 06:23 AM PST As part of a training series Monday morning in Jackson, community health leaders are getting better acquainted with Mississippi's major health care problems and ways to identify them. Those include obesity, diabetes, hypertension and teen pregnancy. Skiing for Diabetes Awareness Tue, 19 Feb, 2013 06:00 AM PST The Third Annual Downhill for Diabetes Charity ski and snowboard event will be Feb. 24 at Pico Mountain Resort in Killington. New advances in the molecular study of diabetes Tue, 19 Feb, 2013 05:58 AM PST A new study describes for the first time the pharmacological action of thiazolidinediones (TZDs) -- anti-diabetic drugs -- directly on the pancreas, the organ which produces insulin. Novo Nordisk celebrates 90 years of diabetes innovation Tue, 19 Feb, 2013 05:10 AM PST Global leader in diabetes care recognizes anniversary of Canadian roots MISSISSAUGA, ON, Feb. 19, 2013 /CNW/ - Danish-based pharmaceutical company Novo Nordisk is celebrating the 90th anniversary of when diabetes patients were first treated with the company's insulin. With its... Supercomputers to keep age-related ailments at bay Tue, 19 Feb, 2013 05:02 AM PST Sydney, Feb 19 : Supercomputers are helping tweak antioxidants to stave off age-related diseases such as cancer, diabetes, heart disease and Alzheimer's, shows a study. NeuroMetrix Reports Q4 2012 Results Tue, 19 Feb, 2013 04:11 AM PST WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today reported business and financial highlights for the quarter and twelve months ended December 31, 2012. The Company is working to develop a high growth, profitable diabetes franchise focused on diabetic peripheral ... | |
|
No comments:
Post a Comment